ACT ETIDROCAL

Active ingredients

The drug ACT ETIDROCAL contains a combination of these active pharmaceutical ingredients (APIs):

UNII M16PXG993G - ETIDRONATE DISODIUM

Etidronate acts primarily on bone. It can inhibit the formation, growth, and dissolution of hydroxyapatite crystals and their amorphous precursors by chemisorption to calcium phosphate surfaces.

Read about Etidronate
UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Read about Calcium carbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
M05BB01
Etidronic acid and calcium, sequential
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BB Bisphosphonates, combinations
Discover more medicines within M05BB01

Authorization and marketing

This brand name is authorized in the following countries: Canada

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02263866